Relationship between the methylenetetrahydrofolate reductase (MTHFR) rs1801133 SNP and serum homocysteine levels of Zhuang hypertensive patients in the central region of Guangxi

키워드

참고문헌 (59)

1. Patel P, "Improved blood pressure control to reduce cardiovascular disease morbidity and mortality : the standardized hypertension treatment and prevention project", J Clin Hypertens(Greenwich), 18, pp.1284~1294 (2016)
2. Wang X, "Prevalence of hypertension in China : a systematic review and meta-regression analysis of trends and regional differences", J Hypertens, 32, pp.1919~1927 (2014)
3. Gao Y, "Prevalence of hypertension in China : a cross-sectional study", PLoS ONE, 8, pp.e65938~ (2013)
4. Oliveras A, "Resistant hypertension : patient characteristics, risk factors, co-morbidities and outcomes", J Hum Hypertens, 28, pp.213~217 (2014)
5. Piskorz D, "Hypertensive mediated organ damage and hypertension management : how to assess beneficial effects of antihypertensive treatments?", High Blood Press Cardiovasc Prev, 27, pp.9~17 (2020)
6. Wenzel UO, "A pathogenic role of complement in arterial hypertension and hypertensive end organ damage", Am J Physiol Heart Circ Physiol, 312, pp.H349~54 (2017)
7. Ruixing Y, "Effects of demographic characteristics, health-related behaviors and lifestyle factors on the prevalence of hypertension for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations", Kidney Blood Press Res, 29, pp.312~320 (2006)
8. Yin R, "Effects of alcohol consumption and other lifestyle behaviors on blood pressure for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations", Alcohol, 41, pp.541~550 (2007)
9. Ruixing Y, "Diet, lifestyle, and blood pressure of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations", Am J Hypertens, 21, pp.382~387 (2008)
10. Wang YJ, "China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases", Stroke Vasc Neurol, 7, pp.415~450 (2022), National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
11. Bin Y, "Prevalence, awareness, treatment, control and the risk factors of hypertension in the chinese Maonan and Han ethnic groups", Int J Clin Exp Med, 10, pp.1209~1223 (2017)
12. Hu XJ, "Prevalence of hypertension and its risk factors in the chinese Mulao and Han populations", Int J Clin Exp Med, 9, pp.4222~4232 (2016)
13. Xie RB, "Prevalence of hypertension and associated risk factors in Chinese Jing compared with Mulao populations", J Int Med Res, 43, pp.819~833 (2015)
14. Wang Z, "Status of hypertension in China : results from the China Hypertension Survey, 2012–2015", Circulation, 137, pp.2344~2356 (2018)
15. Reynolds K, "Geographic variations in the prevalence, awareness, treatment and control of hypertension in China", J Hypertens, 21, pp.1273~1281 (2003)
16. Ruixing Y, "Association of diet and lifestyle with blood pressure in the Guangxi Hei Yi Zhuang and Han populations", Public Health Nutr, 12, pp.553~561 (2009)
17. Wei BL, "CYP17A1-ATP2B1 SNPs and gene-gene and gene-environment interactions on essential hypertension", Front Cardiovasc Med, 8, pp.720884~ (2021)
18. Yin RX, "Interactions of several genetic polymorphisms and alcohol consumption on blood pressure levels", BioFactors, 41, pp.339~351 (2015)
19. Yin RX, "Several lipid-related gene polymorphisms interact with overweight", obesity to modulate blood pressure levels, 2012, pp.13, 12062~12081
20. Yin RX, "Interactions of several lipid-related gene polymorphisms and cigarette smoking on blood pressure levels", Int J Biol Sci, 8, pp.685~696 (2012)
21. Yin RX, "Association of several lipidrelated gene polymorphisms and blood pressure variation in the Bai Ku Yao population", Am J Hypertens, 25, pp.927~936 (2012)
22. Li J, "H-type hypertension and risk of stroke in chinese adults : a prospective, nested case-control study", J Transl Int Med, 3, pp.171~178 (2015)
23. Hu DY, "Prevention of stroke relies on valid control H type hypertension", Zhonghua nei ke za zhi, 47, pp.976~977 (2008)
24. Huo Y, "Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China : the CSPPT randomized clinical trial", JAMA, 313, pp.1325~1335 (2015)
25. Qian XL, "The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China : a cross-section study : prevalence of H type hypertension", BMC Cardiovasc Disord, 21, pp.376~ (2021)
26. Li T, "Analysis of clinical characteristics and influencing factors for H-type hypertension complicated with other chronic diseases in a community in Beijing", Evid Based Complement Alternat Med, 2022, pp.6974065~ (2022)
27. Wang Y, "Prevalence of hyperhomocysteinaemia and its major determinants in rural chinese hypertensive patients aged 45–75 years", Br J Nutr, 109, pp.1284~1293 (2013)
28. Liang Z, "Rate and characteristics of H-type hypertension in chinese hypertensive population and comparison with american population", Beijing Da Xue Xue Bao Yi Xue Ban, 54, pp.1028~1037 (2022)
29. du Plessis JP, "H-type hypertension among Black South Africans and the relationship between homocysteine, its genetic determinants and estimates of vascular function", J Cardiovasc Dev Dis, 9, pp.447~ (2022)
30. Liao S, "Association between methylenetetrahydrofolate reductase(MTHFR)C677T polymorphism and H-type hypertension : a systematic review and meta-analysis", Ann Hum Genet, 86, pp.278~289 (2022)
31. Stea TH, "Changes in predictors and status of homocysteine in young male adults after a dietary intervention with vegetables, fruits and bread", Eur J Nutr, 47, pp.201~209 (2008)
32. Wang W, "Prevalence of hyperhomocysteinemia and its associated factors in patients with primary hypertension in chinese urban communities : a cross-sectional study from Nanjing", Clin Exp Hypertens, 40, pp.495~500 (2018)
33. de Bree A, "Lifestyle factors and plasma homocysteine concentrations in a general population sample", Am J Epidemiol, 154, pp.150~154 (2001)
34. Kripps KA, "Methionine synthase deficiency : variable clinical presentation and benefit of early diagnosis and treatment", J Inherit Metab Dis, 45, pp.157~168 (2022)
35. Zhang C, "Effect of MTHFRC677T gene polymorphism on early morning blood pressure in elderly female patients with H-type hypertension", Contrast Media Mol Imaging, 2022, pp.2530388~ (2022)
36. Zhang C, "Analysis of the correlation between the distribution of MTHFR gene and the severity and renal function of elderly patients with H-type hypertension", J Healthc Eng, 2022, pp.8352005~ (2022)
37. Dai C, "A novel review of homocysteine and pregnancy complications", Biomed Res Int, 2021, pp.6652231~ (2021)
38. Zhang S, "Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension : a double-blinded, randomized clinical cohort study", Med(Baltim), 101, pp.e28628~ (2022)
39. Ou CY, "5, 10methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects", Am J Med Genet, 63, pp.610~614 (1996)
40. Regland B, "The role of the polymorphic genes apolipoprotein E and methylene-tetrahydrofolate reductase in the development of dementia of the Alzheimer type", Dement Geriatr Cogn Disord, 10, pp.245~251 (1999)
41. Nishiyama M, "Methylenetetrahydrofolate reductase(MTHFR)mutation and the risk of senile dementia : an epidemiological study using the polymerase chain reaction(PCR)method", J Epidemiol, 10, pp.163~172 (2000)
42. Fu L, "Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing mendelian randomization", J Clin Hypertens(Greenwich), 21, pp.1879~1894 (2019)
43. Song J, "Polymorphism of MTHFR C677T gene and the associations with the severity of essential hypertension in Northern Chinese population", Int J Hypertens, 2020, pp.1878917~ (2020)
44. Ornosa-Martín G, "Homocysteine, the methylenetetrahydrofolate reductase 677 C >T polymorphism and hypertension : effect modifiers by lifestyle factors and population subgroups", Br J Nutr, 124, pp.69~79 (2020)
45. Huang LW, "Association of the methylenetetrahydrofolate reductase(MTHFR)gene variant C677T with serum homocysteine levels and the severity of ischaemic stroke : a case-control study in the southwest of China", J Int Med Res, 50 (2022)
46. Yun L, "Homocysteine and the C677T gene polymorphism of its key metabolic enzyme MTHFR are risk factors of early renal damage in hypertension in a chinese Han population", Med(Baltim), 94, pp.e2389~ (2015)
47. Mabhida SE, "Methylenetetrahydrofolate reductase polymorphism(rs1801133)and the risk of hypertension among african populations : a narrative synthesis of literature", Genes(Basel), 13, pp.631~ (2022)
48. Huang LQ, "Clinical characteristics of H-type hypertension and its relationship with the MTHFR C677T polymorphism in a Zhuang population from Guangxi, China", J Clin Lab Anal, 34, pp.e23499~ (2020)
49. Gauderman WJ, "Sample size requirements for association studies of genegene interaction", Am J Epidemiol, 155, pp.478~484 (2002)
50. Burton PR, "Size matters : just how big is BIG? : quantifying realistic sample size requirements for human genome epidemiology", Int J Epidemiol, 38, pp.263~273 (2009)
51. Xu R, "Gender-and age-related differences in homocysteine concentration : a cross-sectional study of the general population of China", Sci Rep, 10, pp.17401~ (2020)
52. Li P, "The study status of homocysteine in patients with hypertension disorder complicating pregnancy", Contemp Med, 24, pp.189~192 (2018)
53. Na K, "Attention should be paid to the relationship between homocysteinemia and hypertension", Chin J Clin, 38, pp.3~6 (2010)
54. Gelber RP, "A prospective study of body mass index and the risk of developing hypertension in men", Am J Hypertens, 20, pp.370~377 (2007)
55. Davy KP, "Obesity and hypertension: two epidemics or one?", Am J Physiol Regul Integr Comp Physiol, 286, pp.R803~R813 (2004)
56. Willig AL, "Adjusting adiposity and body weight measurements for height alters the relationship with blood pressure in children", Am J Hypertens, 23, pp.904~910 (2010)
57. Lurbe E, "Management of high blood pressure in children and adolescents : recommendations of the European Society of hypertension", An Pediatr(Barc), 73, pp.51~ (2010)
58. Qin X, "MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive chinese adults", Nutr J, 11, pp.2~ (2012)
59. Qin X, "Effect of folic acid intervention on the change of serum folate level in hypertensive chinese adults : do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses?", Pharmacogenet Genomics, 22, pp.421~428 (2012)

관련 논문AI추천